# Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression

> **NCT01583023** · PHASE4 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 45 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Bupropion
- **DEVICE:** Active Repetitive Transcranial Magnetic Stimulation
- **OTHER:** Placebo
- **DEVICE:** Sham repetitive transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT01583023
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2014-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01583023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01583023, "Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01583023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*